Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tachykinin receptor 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | 0.0252 | 0.1862 | 1 | |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.019 | 0.1213 | 0.4865 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.019 | 0.1213 | 0.6617 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.025 | 0.1833 | 0.1833 |
Plasmodium falciparum | plasmepsin IV | 0.025 | 0.1833 | 0.465 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0175 | 0.1058 | 0.5 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0095 | 0.022 | 0.022 |
Brugia malayi | proprotein convertase 2 | 0.0197 | 0.1281 | 0.4665 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.1032 | 1 | 1 |
Trypanosoma brucei | N-myristoyltransferase | 0.0175 | 0.1058 | 0.5 |
Onchocerca volvulus | 0.0095 | 0.022 | 0.5 | |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0175 | 0.1058 | 0.5679 |
Plasmodium falciparum | plasmepsin I | 0.025 | 0.1833 | 0.465 |
Plasmodium falciparum | plasmepsin II | 0.025 | 0.1833 | 0.465 |
Plasmodium vivax | aspartyl proteinase, putative | 0.025 | 0.1833 | 0.465 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0175 | 0.1058 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0115 | 0.043 | 0.2347 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0175 | 0.1058 | 0.5 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.025 | 0.1833 | 1 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0313 | 0.2494 | 1 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.025 | 0.1833 | 0.465 |
Leishmania major | N-myristoyl transferase, putative | 0.0175 | 0.1058 | 0.5 |
Onchocerca volvulus | 0.0095 | 0.022 | 0.5 | |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Brugia malayi | celfurPC protein | 0.0252 | 0.1862 | 0.7223 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0175 | 0.1058 | 0.2414 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.022 | 0.0882 |
Plasmodium falciparum | plasmepsin IX | 0.0427 | 0.369 | 1 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.019 | 0.1213 | 0.6515 |
Loa Loa (eye worm) | aspartyl protease 6 | 0.0095 | 0.022 | 0.0882 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0175 | 0.1058 | 0.2414 |
Plasmodium falciparum | plasmepsin VI | 0.025 | 0.1833 | 0.465 |
Echinococcus granulosus | furin | 0.0313 | 0.2494 | 1 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0136 | 0.0649 | 0.0649 |
Loa Loa (eye worm) | hypothetical protein | 0.025 | 0.1833 | 0.7352 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.051 | 0.2043 |
Loa Loa (eye worm) | hypothetical protein | 0.0313 | 0.2494 | 1 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0197 | 0.1281 | 0.5135 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.025 | 0.1833 | 0.7352 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.0175 | 0.1058 | 0.4241 |
Plasmodium vivax | plasmepsin IV, putative | 0.025 | 0.1833 | 0.465 |
Brugia malayi | N-myristoyltransferase 2 | 0.0175 | 0.1058 | 0.3684 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.0197 | 0.1281 | 0.4665 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.022 | 0.0882 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0175 | 0.1058 | 0.4241 |
Plasmodium vivax | aspartyl protease, putative | 0.0427 | 0.369 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.019 | 0.1213 | 0.6617 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.025 | 0.1833 | 0.465 |
Giardia lamblia | CDC72 | 0.0175 | 0.1058 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0175 | 0.1058 | 0.5 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.0427 | 0.369 | 1 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0175 | 0.1058 | 0.5768 |
Loa Loa (eye worm) | aspartic protease BmAsp-1 | 0.0095 | 0.022 | 0.0882 |
Schistosoma mansoni | N-myristoyltransferase | 0.0175 | 0.1058 | 0.1058 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.025 | 0.1833 | 0.9845 |
Brugia malayi | endoprotease bli-4 precursor | 0.0313 | 0.2494 | 1 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0197 | 0.1281 | 0.6877 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.025 | 0.1833 | 0.7352 |
Plasmodium falciparum | plasmepsin X | 0.0427 | 0.369 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0095 | 0.022 | 0.022 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0313 | 0.2494 | 0.2494 |
Plasmodium vivax | aspartyl protease, putative | 0.0427 | 0.369 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 3.1 uM | Bindining affinity for human tachykinin receptor 2 was measured by using [125I]-NKA as radio ligand | ChEMBL. | 15664817 |
Ki (binding) | = 3.1 uM | Bindining affinity for human tachykinin receptor 2 was measured by using [125I]-NKA as radio ligand | ChEMBL. | 15664817 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.